256
Participants
Start Date
April 30, 2004
Study Completion Date
March 31, 2005
Aripiprazole
Oral aripiprazole capsules 15 mg once daily from Days 1-14; thereafter, doses could be adjusted on Days 14 and 21 to 10, 15, or 30 mg once daily; patients treated for 28 days
Ziprasidone
Oral ziprasidone capsules 40 mg twice daily on Day 1, 60 mg twice daily on Day 2, 80 mg twice daily on Days 3-14; thereafter, doses could be adjusted on Days 14 and 21 to 40, 60, or 80 mg twice daily; patients treated for 28 days
Pfizer Investigational Site, Staten Island
Pfizer Investigational Site, Jamaica
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Rockville
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Falls Church
Pfizer Investigational Site, Arlington
Pfizer Investigational Site, Arlington
Pfizer Investigational Site, Butner
Pfizer Investigational Site, Raleigh
Pfizer Investigational Site, Durham
Pfizer Investigational Site, Hialeah
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Shreveport
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Irving
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Bellaire
Pfizer Investigational Site, Culver City
Pfizer Investigational Site, Torrance
Pfizer Investigational Site, Cerritos
Pfizer Investigational Site, Paramount
Pfizer Investigational Site, Glendale
Pfizer Investigational Site, Upland
Pfizer Investigational Site, La Mesa
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Riverside
Pfizer Investigational Site, Newport Beach
Pfizer Investigational Site, Anaheim
Pfizer Investigational Site, Garden Grove
Pfizer Investigational Site, Clementon
Pfizer Investigational Site, Princeton
Pfizer Investigational Site, Willingboro
Pfizer Investigational Site, Woodlane
Pfizer Investigational Site, Chapel Hill
Pfizer Investigational Site, Cincinnati
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY